Nucleotides Regulate Secretion of the Inflammatory Chemokine CCL2 from Human Macrophages and Monocytes

被引:11
作者
Higgins, K. R. [1 ]
Kovacevic, W. [1 ]
Stokes, L. [1 ,2 ]
机构
[1] Univ Sydney, Sydney Med Sch Nepean, Penrith, NSW 2750, Australia
[2] RMIT Univ, Sch Med Sci, Hlth Innovat Res Inst, Bundoora, Vic 3083, Australia
关键词
P2Y(2) RECEPTORS; RAT ALVEOLAR; POLYMORPHISM; EXPRESSION; RELEASE; LIPOPOLYSACCHARIDE; IDENTIFICATION; HAPLOTYPES; IL-1-BETA; CELLS;
D O I
10.1155/2014/293925
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CCL2 is an important inflammatory chemokine involved in monocyte recruitment to inflamed tissues. The extracellular nucleotide signalling molecules UTP and ATP acting via the P2Y2 receptor are known to induce CCL2 secretion in macrophages. We confirmed this in the human THP-1 monocytic cell line showing that UTP is as efficient as LPS at inducing CCL2 at early time points (2-6 hours). Expression and calcium mobilisation experiments confirmed the presence of functional P2Y2 receptors on THP-1 cells. UTP stimulation of human peripheral CD14+ monocytes showed low responses to LPS (4-hour stimulation) but a significant increase above background following 6 hours of treatment. The response to UTP in human monocytes was variable and required stimulation >6 hours. With such variability in response we looked for single nucleotide polymorphisms in P2RY2 that could affect the functional response. Sequencing of P2RY2 from THP-1 cells revealed the presence of a single nucleotide polymorphism altering amino acid 312 from arginine to serine (rs3741156). This polymorphism is relatively common at a frequency of 0.276 (n = 404 subjects). Finally, we investigated CCL2 secretion in response to LPS or UTP in human macrophages expressing 312Arg-P2Y2 or 312Ser-P2Y2 where only the latter exhibited significant UTP-induced CCL2 secretion (n = 5 donors per group).
引用
收藏
页数:13
相关论文
共 29 条
[1]   International union of pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy [J].
Abbracchio, Maria P. ;
Burnstock, Geoffrey ;
Boeynaems, Jean-Marie ;
Barnard, Eric A. ;
Boyer, Jose L. ;
Kennedy, Charles ;
Knight, Gillian E. ;
Fumagalli, Marta ;
Gachet, Christian ;
Jacobson, Kenneth A. ;
Weisman, Gary A. .
PHARMACOLOGICAL REVIEWS, 2006, 58 (03) :281-341
[2]   Concomitant activation of P2Y2 and P2Y6 receptors on monocytes is required for TLR1/2-induced neutrophil migration by regulating IL-8 secretion [J].
Ben Yebdri, Fethia ;
Kukulski, Filip ;
Tremblay, Alain ;
Sevigny, Jean .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (10) :2885-2894
[3]   P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages [J].
Bowler, JW ;
Bailey, RJ ;
North, RA ;
Surprenant, A .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (03) :567-575
[4]  
Büscher R, 2006, PHARMACOGENET GENOM, V16, P199
[5]  
Ciesielski CJ, 2002, EUR J IMMUNOL, V32, P2037, DOI 10.1002/1521-4141(200207)32:7<2037::AID-IMMU2037>3.0.CO
[6]  
2-I
[7]   The P2Y2 Nucleotide Receptor Mediates Tissue Factor Expression in Human Coronary Artery Endothelial Cells [J].
Ding, Ling ;
Ma, Wanshu ;
Littmann, Timothy ;
Camp, Riley ;
Shen, Jianzhong .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (30) :27027-27038
[8]   Increased susceptibility of purinergic receptor-deficient mice to lung infection with Pseudomonas aeruginosa [J].
Geary, C ;
Akinbi, H ;
Korfhagen, T ;
Fabre, JE ;
Boucher, R ;
Rice, W .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2005, 289 (05) :L890-L895
[9]  
Humphreys BD, 1996, J IMMUNOL, V157, P5627
[10]   Development of selective agonists and antagonists of P2Y receptors [J].
Jacobson, Kenneth A. ;
Ivanov, Andrei A. ;
de Castro, Sonia ;
Harden, T. Kendall ;
Ko, Hyojin .
PURINERGIC SIGNALLING, 2009, 5 (01) :75-89